PRIMARY-HF: Heart Failure Screening in Primary Care Using Point-of- Care (PRIMARY-HF)
PRIMARY-HF: Diagnóstico de Insuficiência Cardíaca em Cuidados de Saúde Primários Utilizando Ecografia Point-of-Care e Péptidos Natriuréticos
The goal of this clinical trial is to evaluate whether the use of NT-proBNP testing and point-of-care ultrasound (POCUS) can improve the diagnosis and management of heart failure in adults aged 50 years or older with suspected heart failure or cardiovascular risk factors in primary care settings.
The main questions it aims to answer are:
- Does the use of NT-proBNP and/or POCUS increase the rate of new heart failure diagnoses compared with standard care?
- Does this approach support earlier initiation of guideline-directed medical therapy and improve patients' quality of life?
Researchers will compare standard care alone with standard care combined with NT-proBNP testing, POCUS, or both, to assess their impact on diagnosis and management of heart failure.
Participants will:
- Be randomly assigned to one of four groups (standard care, NT-proBNP, POCUS, or both).
- Undergo clinical evaluation for heart failure according to their assigned group.
- Be followed for 12 months with periodic assessments of quality of life and treatment adherence.
調査の概要
状態
条件
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Jonathan dos Santos, MD.
- メール:jonathan.santos@ua.pt
研究場所
-
-
-
Amadora、ポルトガル
- まだ募集していません
- Unidade de Saúde Familiar Conde da Lousã
-
コンタクト:
- Miguel Henriques
- 電話番号:(+351) 914 338 519
- メール:miguelcachinho@gmail.com
-
Lisbon、ポルトガル
- まだ募集していません
- Unidade de Saúde Familiar do Parque
-
コンタクト:
- Joana Gonçalves
- 電話番号:(+351) 961 703 789
- メール:joana.goncalves@ulssm.min-saude.pt
-
Lisbon、ポルトガル
- まだ募集していません
- Unidade de Saúde Familiar Rodrigues Miguéis
-
コンタクト:
- Inês Santos
- 電話番号:(+351) 911 178 033
- メール:inessalmeidasantos@gmail.com
-
Porto、ポルトガル
- 募集
- Unidade de Saúde Familiar Garcia Orta
-
コンタクト:
- Rita Queirós
- 電話番号:(+351) 917 257 162
- メール:queiros.rita.ana@gmail.com
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Adults aged ≥50 years
- Suspected heart failure (based on signs and/or symptoms) OR
Presence of at least two cardiovascular risk factors, including:
- Diabetes mellitus
- Arterial hypertension
- Estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m²
- Albuminuria
- Coronary artery disease or prior myocardial infarction or coronary revascularization
- Stroke or transient ischemic attack
- Atrial fibrillation or flutter
- Left ventricular hypertrophy or Q waves on electrocardiogram
- Obesity (body mass index ≥30 kg/m²)
- Ability to provide written informed consent
Exclusion Criteria:
- Known heart failure under active hospital-based follow-up
- Terminal illness or life expectancy <1 year
- Severe comorbid conditions limiting participation or follow-up
- Inability to provide informed consent
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:診断
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:Standard of care
Participants receive standard clinical evaluation and management in primary care without NT-proBNP testing and without point-of-care ultrasound (POCUS).
|
Usual clinical evaluation and management in primary care according to standard practice, without additional diagnostic interventions specified in the study.
|
|
アクティブコンパレータ:Standard of care + NT-proBNP
Participants receive standard clinical evaluation and management in primary care with NT-proBNP testing, but without point-of-care ultrasound (POCUS).
|
Usual clinical evaluation and management in primary care according to standard practice, without additional diagnostic interventions specified in the study.
Measurement of N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in blood as part of the diagnostic evaluation for suspected heart failure in primary care.
|
|
実験的:Standard of care + NT-proBNP + POCUS
Participants receive standard clinical evaluation and management in primary care with NT-proBNP testing and cardiac point-of-care ultrasound (POCUS).
|
Usual clinical evaluation and management in primary care according to standard practice, without additional diagnostic interventions specified in the study.
Measurement of N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in blood as part of the diagnostic evaluation for suspected heart failure in primary care.
Cardiac point-of-care ultrasound performed by trained primary care physicians to assess cardiac structure and function as part of the diagnostic evaluation for suspected heart failure.
|
|
実験的:Standard of care + POCUS
Participants receive standard clinical evaluation and management in primary care with cardiac point-of-care ultrasound (POCUS), but without NT-proBNP testing.
|
Usual clinical evaluation and management in primary care according to standard practice, without additional diagnostic interventions specified in the study.
Cardiac point-of-care ultrasound performed by trained primary care physicians to assess cardiac structure and function as part of the diagnostic evaluation for suspected heart failure.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
New Heart Failure Diagnosis
時間枠:From baseline to 12 months
|
Proportion of participants with a new diagnosis of heart failure established during follow-up based on clinical evaluation and diagnostic testing according to routine practice.
|
From baseline to 12 months
|
|
Initiation of Guideline-Directed Medical Therapy (GDMT)
時間枠:From baseline to 12 months
|
Proportion of participants in whom guideline-directed medical therapy for heart failure is initiated during follow-up.
|
From baseline to 12 months
|
|
Change in Health-Related Quality of Life (KCCQ-12)
時間枠:From baseline to 12 months
|
Change from baseline in health-related quality of life as measured by the Kansas City Cardiomyopathy Questionnaire 12 (KCCQ-12) score.
|
From baseline to 12 months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Cost-effectiveness of diagnostic strategies
時間枠:From baseline to 12 months
|
Evaluation of the cost-effectiveness of diagnostic strategies incorporating NT-proBNP testing and/or point-of-care ultrasound (POCUS), including direct healthcare costs (e.g., diagnostic testing and referrals) and indirect costs (e.g., patient time and productivity loss).
|
From baseline to 12 months
|
|
Quality of Cardiac POCUS Examinations
時間枠:From baseline to 12 months
|
Assessment of the quality and interpretability of cardiac point-of-care ultrasound (POCUS) examinations performed by trained primary care physicians, based on expert review.
|
From baseline to 12 months
|
|
Healthcare Resource Utilization
時間枠:From baseline to 12 months
|
Assessment of healthcare resource utilization, including the number of conventional echocardiograms performed and referrals to specialist care.
|
From baseline to 12 months
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Jonathan dos Santos、Aveiro University
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- PRIMARY-HF
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。